Catalog No.: PC-21763Not For Human Use, Lab Use Only.
VBY-825 is an reversible cathepsin inhibitor of cathepsins B, L, S and V.with Ki values of 130/250/250/330/2.3/4.7 nM (cathepsin S/L/ZV/Bhumanized-rabbit cathepsin K/cathepsin F).
VBY-825 is an reversible cathepsin inhibitor of cathepsins B, L, S and V.with Ki values of 130/250/250/330/2.3/4.7 nM (cathepsin S/L/ZV/Bhumanized-rabbit cathepsin K/cathepsin F). VBY-825 significantly decreases tumor burden and tumor number in pre-clinical model of pancreatic islet cancer. VBY-825 antagonizes SARS coronavirus 2 (SARS-CoV-2) viral replication.
